CARLOS JUAN LUMBRERAS BERMEJO-rekin lankidetzan egindako argitalpenak (3)

2015

  1. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 8, pp. 1112-1119

1995

  1. Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV- seropositive heart transplant recipients treated with OKT3

    Antimicrobial Agents and Chemotherapy

1992

  1. Prophylactic administration of ganciclovir in heart transplant recipients treated with OKT3 [1]

    Transplantology: Journal of Cell and Organ Transplantation